GSK: research collaboration with Flagship Pioneering

(CercleFinance.com) - GSK announces a collaboration with Flagship Pioneering to discover and develop innovative medicines and vaccines, focusing initially on the respiratory and immunological fields.


GSK will contribute its therapeutic expertise and development know-how, while Flagship will contribute its network of bioplatform companies and innovative technologies.

Initially, the companies will invest up to $150m in an exploration phase.

The aim is to select up to 10 promising new drugs and vaccines for further clinical development by GSK.

Flagship and its companies could receive up to $720m in payments and royalties for each program acquired.


Copyright (c) 2024 CercleFinance.com. All rights reserved.